Physical Activity, Screen Time, and Emotional Well-Being During the 2019 Novel Coronavirus Outbreak in China
Overview
Public Health
Affiliations
We aimed to evaluate the effects of the COVID-19 lock down on lifestyle in China during the initial stage of the pandemic. A questionnaire was distributed to Chinese adults living in 31 provinces of China via the internet using a snowball sampling strategy. Information on 7-day physical activity recall, screen time, and emotional state were collected between January 24 and February 2, 2020. ANOVA, χ² test, and Spearman's correlation coefficients were used for statistical analysis. 12,107 participants aged 18-80 years were included. During the initial phase of the COVID-19 outbreak, nearly 60% of Chinese adults had inadequate physical activity (95% CI 56.6%-58.3%), which was more than twice the global prevalence (27.5%, 25.0%-32.2%). Their mean screen time was more than 4 hours per day while staying at home (261.3 ± 189.8 min per day), and the longest screen time was found in young adults (305.6 ± 217.5 min per day). We found a positive and significant correlation between provincial proportions of confirmed COVID-19 cases and negative affect scores (r = 0.501, = 0.004). Individuals with vigorous physical activity appeared to have a better emotional state and less screen time than those with light physical activity. During this nationwide lockdown, more than half of Chinese adults temporarily adopted a sedentary lifestyle with insufficient physical activity, more screen time, and poor emotional state, which may carry considerable health risks. Promotion of home-based self-exercise can potentially help improve health and wellness.
Thematic analysis of COVID-19's impacts on transitions among emerging adults.
Bieniak K, Bedree H, Geanous N, Greenley R, Miller S, Buscemi J Health Care Transit. 2024; 2:100052.
PMID: 39712585 PMC: 11657545. DOI: 10.1016/j.hctj.2024.100052.
Basuodan R, Gmmash A, Alghadier M, Albesher R Healthcare (Basel). 2024; 12(16).
PMID: 39201193 PMC: 11353332. DOI: 10.3390/healthcare12161635.
Bifolco G, Cardinali L, Mocini E, Duradoni M, Baldari C, Ciampi M Endocrine. 2024; 86(3):1003-1013.
PMID: 39177928 PMC: 11554811. DOI: 10.1007/s12020-024-03950-w.
Li D, Chua T, Chen M, Li X, Chia M BMC Public Health. 2024; 24(1):2184.
PMID: 39135153 PMC: 11320779. DOI: 10.1186/s12889-024-19714-0.
Chen M, Padmapriya N, Chua X, Escobosa L, Tay A, Tai B BMC Public Health. 2024; 24(1):2097.
PMID: 39095795 PMC: 11297782. DOI: 10.1186/s12889-024-19608-1.